110 related articles for article (PubMed ID: 37580734)
1. Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
J Hematol Oncol; 2023 Aug; 16(1):95. PubMed ID: 37580734
[No Abstract] [Full Text] [Related]
2. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
[TBL] [Abstract][Full Text] [Related]
3. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
[TBL] [Abstract][Full Text] [Related]
4. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
5. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis.
Qian CJ; Xu ZR; Chen LY; Wang YC; Yao J
Cancer Manag Res; 2020; 12():6895-6908. PubMed ID: 32801913
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis.
Yu Z; Wang Y; Deng J; Liu D; Zhang L; Shao H; Wang Z; Zhu W; Zhao C; Ke Q
Bioengineered; 2021 Dec; 12(1):6251-6263. PubMed ID: 34477476
[TBL] [Abstract][Full Text] [Related]
9. Retraction Notice to: Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2023 Jun; 31(6):1857. PubMed ID: 37172590
[No Abstract] [Full Text] [Related]
10. Retraction Note: Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
J Exp Clin Cancer Res; 2023 Mar; 42(1):58. PubMed ID: 36890562
[No Abstract] [Full Text] [Related]
11. The Long Noncoding RNA Hepatocyte Nuclear Factor 4
Wang P; Chen S; Wang Y; Wang X; Yan L; Yang K; Zhong XB; Han S; Zhang L
Drug Metab Dispos; 2021 May; 49(5):361-368. PubMed ID: 33674270
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
[TBL] [Abstract][Full Text] [Related]
13. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-MCM3AP-AS1 Promotes the Progression of Infantile Hemangiomas by Increasing miR-138-5p/HIF-1α Axis-Regulated Glycolysis.
Mei H; Xian H; Ke J
Front Mol Biosci; 2021; 8():753218. PubMed ID: 34660700
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.
Wang X; Guo Y; Chen G; Fang E; Wang J; Li Q; Li D; Hu A; Bao B; Zhou Y; Gao H; Song J; Du X; Zheng L; Tong Q
Oncogene; 2023 Sep; 42(36):2673-2687. PubMed ID: 37537343
[TBL] [Abstract][Full Text] [Related]
18. RPL35 promotes neuroblastoma progression via the enhanced aerobic glycolysis.
Wu W; Yu N; Li F; Gao P; Lin S; Zhu Y
Am J Cancer Res; 2021; 11(11):5701-5714. PubMed ID: 34873488
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA OIP5-AS1 promotes cell proliferation and aerobic glycolysis in gastric cancer through sponging miR-186.
Huang J; Hou S; Xu J; Wu J; Yin J
Arch Med Sci; 2021; 17(6):1742-1751. PubMed ID: 34900056
[TBL] [Abstract][Full Text] [Related]
20. HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
Song H; Wang J; Wang X; Yuan B; Li D; Hu A; Guo Y; Cai S; Jin S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q
Oncogene; 2022 Apr; 41(17):2505-2519. PubMed ID: 35318442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
